Know Cancer

or
forgot password


N/A
20 Years
43 Years
Not Enrolling
Female
The Investigators Collected 534 PCOS Patients as the Case Group,and 580 Infertile Women With Normal Ovulatory Cycle of the Control Group;, At the Same Time, the Investigators Continuedly Collect Cases to October 2012, and Totally Collected 579 Patients With PCOS Altogether;, 534 Patients in the Cases Group and 580 Women in the Control Group Received no Measures, While 579 Patients Received Drugs;, The Investigators Monitored Basic Indexes in Blood of All the Subjects in This Suvey,and Also Monitored Indexes of 579 Patients After Treatment.

Thank you

Trial Information


Inclusion Criteria:



- The clinical diagnosis criteria for PCOS by European Society of Human Reproduction
and Embryology, and Rotterdam working group of American Society for Reproductive
Medicine (ESHRE /ASRM )

Exclusion Criteria:

- hyperprolactinemia and other endocrine diseases such as high androgen hormone in
blood, namely Cushing's syndrome, congenital adrenal hyperplasia ( CAH ), ovarian or
adrenal tumor and so on

Type of Study:

Observational

Study Design:

Observational Model: Case Control

Outcome Measure:

The potentially biochemical diagnosis criteria and therapeutic effect evaluation indexes: Sex hormone binding globulin levels and free androgen index in blood of patients with polycystic ovary syndrome

Outcome Time Frame:

after 5 weeks of ovulation treatment

Safety Issue:

Yes

Authority:

United States: Food and Drug Administration

Study ID:

2006A165

NCT ID:

NCT01784380

Start Date:

October 2006

Completion Date:

October 2012

Related Keywords:

  • The Investigators Collected 534 PCOS Patients as the Case Group,and 580 Infertile Women With Normal Ovulatory Cycle of the Control Group;
  • At the Same Time, the Investigators Continuedly Collect Cases to October 2012, and Totally Collected 579 Patients With PCOS Altogether;
  • 534 Patients in the Cases Group and 580 Women in the Control Group Received no Measures, While 579 Patients Received Drugs;
  • The Investigators Monitored Basic Indexes in Blood of All the Subjects in This Suvey,and Also Monitored Indexes of 579 Patients After Treatment.
  • Polycystic Ovary Syndrome

Name

Location